First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial
Go back to First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial| (NASDAQ: ACON) | Delayed: 2.28 -0.08 (3.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.36 | 52 Week High | $ | |||
| Open | $2.33 | 52 Week Low | $ | |||
| Day High | $2.37 | P/E | N/A | |||
| Day Low | $2.28 | EPS | $ | |||
| Volume | 34,518 | |||||
| (NASDAQ: ACONW) | Delayed: 0.02 -0.01 (33.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.03 | 52 Week High | $ | |||
| Open | $0.03 | 52 Week Low | $ | |||
| Day High | $0.03 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $ | |||
| Volume | 9,638 | |||||
